期刊文献+
共找到505篇文章
< 1 2 26 >
每页显示 20 50 100
Glaucoma drainage device implantation and cyclophotocoagulation in the management of refractory glaucoma after Descemet-stripping automated endothelial keratoplasty
1
作者 Min-Shu Wang Xue-Chuan Dong +4 位作者 Mi-Yun Zheng Xiang Fan Ge-Ge Xiao Jing Hong Ling-Ling Wu 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2024年第2期257-264,共8页
AIM:To compare the surgical outcomes of glaucoma drainage device implantation(GDI)and trans-scleral neodymium:YAG cyclophotocoagulation(CPC)in the management of refractory glaucoma after Descemetstripping automated en... AIM:To compare the surgical outcomes of glaucoma drainage device implantation(GDI)and trans-scleral neodymium:YAG cyclophotocoagulation(CPC)in the management of refractory glaucoma after Descemetstripping automated endothelial keratoplasty(DSAEK).METHODS:This retrospective study on observational case series enrolled 29 patients who underwent DSAEK and posterior anti-glaucoma surgery(15 with GDI and 14 with CPC).The main outcome measures were intraocular pressure(IOP),glaucoma surgery success rate(defined as IOP of 6–21 mm Hg without additional anti-glaucoma operation),number of glaucoma medications,endothelial graft status,and best-corrected visual acuity(BCVA).RESULTS:The mean follow-up time was 34.1 and 21.0mo for DSAEK or glaucoma surgeries,both for the GDI and CPC groups.Both groups showed significant IOP reduction after glaucoma surgery.The GDI group presented a significantly higher success rate in IOP control than the CPC group(60%vs 21.4%,P=0.03).Both procedures significantly decreased the number of glaucoma medications(P=0.03).Forty percent and 57%of cases in the GDI and the CPC group,respectively,experienced endothelial graft failure during follow-up(P=0.36).Significantly worse BCVA after surgery was observed in the CPC group but not in the GDI group.CONCLUSION:Both GDI and CPC significantly decrease IOP in eyes with glaucoma after DSAEK.GDI is preferable to CPC in refractory glaucoma cases after DSAEK,as it manifests a significantly higher success rate for IOP control,similar endothelial graft failure rate,and relatively preserves BCVA than CPC. 展开更多
关键词 glaucoma drainage device implantation CYCLOPHOTOCOAGULATION refractory glaucoma Descemetstripping automated endothelial keratoplasty
下载PDF
Intraocular pressure control of a novel glaucoma drainage device-in vitro and in vivo studies 被引量:2
2
作者 Li-Jun Cui Di-Chen Li +2 位作者 Jian Liu Lei Zhang Yao Xing 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2017年第9期1354-1360,共7页
AIM:To evaluate the intraocular pressure(IOP)control of an artificial trabeculum drainage system(ATDS),a newly designed glaucoma drainage device,and postoperative complications in normal rabbit eyes.METHODS:Pres... AIM:To evaluate the intraocular pressure(IOP)control of an artificial trabeculum drainage system(ATDS),a newly designed glaucoma drainage device,and postoperative complications in normal rabbit eyes.METHODS:Pressure drops in air and fluid of 30 ATDS were measured after being connected to a closed manometric system.Twenty of them were then chosen and implanted randomly into the eyes of 20 rabbits.Postoperative slitlamp,gonioscopic examination and IOP measurements were recorded periodically.Ultrasound biomicroscopy and B-scan ultrasonography were also used to observe the complications.Eyes were enucleated on day 60.RESULTS:Pressure drops of 4.6-9.4 mm Hg were obtained at physiological aqueous flow rates in the tests in vitro.The average postoperative IOP of the experimental eyes(11.6-12.8 mm Hg)was lower than the controls significantly(P〈0.05)at each time point.Complications of hemorrhage(n=1),cellulosic exudation(two cases)and local iris congestion(two cases)were observed.The lumina of the devices were devoid of obstructions in all specimens examined and a thin fibrous capsule was found around the endplate.CONCLUSION:ATDS reduce IOP effectively.However,further studies on the structure are needed to reduce complications. 展开更多
关键词 drainage device aqueous humor OUTFLOW intraocular pressure RABBIT
下载PDF
Dellen-like keratopathy associated with glaucoma drainage devices
3
作者 Carlton Robert Fenzl Majid Moshirfar +2 位作者 Adam John Gess Valliammai Muthappan Jason Goldsmith 《World Journal of Clinical Cases》 SCIE 2014年第1期1-4,共4页
To report the first case of dellen-like keratopathy with superior corneal thinning associated with implantation of glaucoma drainage devices. A 70-year-old male with a history of primary open angle glaucoma and dry ey... To report the first case of dellen-like keratopathy with superior corneal thinning associated with implantation of glaucoma drainage devices. A 70-year-old male with a history of primary open angle glaucoma and dry eye disease underwent placement of glaucoma drainage devices with antimetabolite application in both eyes. Prior to placement, minimal refractive error was noted on manifest refraction. Several years later, the patient was referred for decreased vision and corneal irregularity. Examination showed pathologic corneal curvature, superior corneal thinning, and epithelial demarcation lines immediately anterior to the glaucoma drainage devices in both eyes. The epithelium remained intact with no evidence of limbal stem cell deficiency. Manifest refraction revealed a large change in both eyes. Topography was used to confirm the presence of irregular corneal curvature anterior to the glaucoma drainage devices. Dellen-like keratopathy with superior thinning is a rare sequela after implantation of a glaucoma drainage device that must be considered in elderly patients who undergo glaucoma surgery. It is likely related to a combination of tear film alteration related to previously large anterior blebs, antimetabolite application, and aqueous humor flow patterns around the drainage devices. Treatment should focus on lubrication. 展开更多
关键词 Dellen-like KERATOPATHY Delle Glaucoma drainage device Corneal THINNING
下载PDF
A portable,economic drainage device to prevent pocket hematoma of pacemakers
4
作者 Wang Haiyan Xue Yusheng +6 位作者 Zheng Qiangsun Liu Yin Tang Yanling Wang Yi Zhang Luxing JiaZhixin Huang Jianbo 《Journal of Medical Colleges of PLA(China)》 CAS 2009年第3期167-175,共9页
Objective:To make up a portable,economic drainage device to prevent the development of pocket hematoma and avoid the additional therapies of pocket hematoma.Methods:Between 2003 and 2006,a total of 265 devices were im... Objective:To make up a portable,economic drainage device to prevent the development of pocket hematoma and avoid the additional therapies of pocket hematoma.Methods:Between 2003 and 2006,a total of 265 devices were implanted at our institution.The 89 high-risk patients were determined by the predictors of hematoma occurrence(marasmatic elder,inevitable oral antiplatelet/anticoagulation therapy,venous pressure increased by other comorbidity,the deficiency of the clotting mechanism for hepatic diseases,or incognizable severe intraoperative bleeding),and other 186 patients were included in non-high-risk group.The 89 high-risk patients were randomized into treatment and control subgroups by sortition.Surgical procedures differed only by the application of the portable,economic drainage device prior to wound closure in treatment subgroup.Results:The incidence of pocket hematoma was 4.3% in treatment subgroup,18.6% in control subgroup and 2.7% in non-high-risk group,leading to 2,6 and 3 patients' prolonged hospitalization,respectively.The additional cost due to pocket hematoma was lower(1.5 times) in the treatment group compared to the control group.There wasn't antidromic infection and delayed cure of the skin incision with the use of our drainage device within 6 months.Conclusion:Our portable drainage device was made up easily and quickly.It could decrease the total cost of hospitalization,did not increase the other adverse events and seemed to be suitable for such patients with a tendency to develop pocket hematoma undergoing the implantation of pectoral pacemakers,implantable cardioverter defibrillator,or cardiac resynchronization therapy. 展开更多
关键词 PACEMAKER Pocket hematoma drainage device
下载PDF
Binocular disturbance after glaucoma drainage device implantation
5
作者 Ta Chen Chang Kara M Cavuoto 《World Journal of Ophthalmology》 2014年第3期25-28,共4页
Binocular vision disturbance is a well-described complication of glaucoma drainage device(GDD) implantation. The pathophysiology is not well-understood, but may involve bulk effects from the implant and surrounding bl... Binocular vision disturbance is a well-described complication of glaucoma drainage device(GDD) implantation. The pathophysiology is not well-understood, but may involve bulk effects from the implant and surrounding bleb, as well as modulation of muscle function due to surgical trauma and post-operative inflammation, resulting in a combined resection/posterior fixation effect. Retrospective studies have found the risks of motility disorder and diplopia vary widely, estimated to be 56%-86% and 57%-75%, respectively. More recently, cross-sectional studies and prospective trials estimate post-GDD incidence to be approximately 1%-44%, with the incidence in newer generation of implants designed to limit bleb size likely lower at 1%-5%. Suggested methods of management strategies include prismatic spectacles, monocular occlusion, extreme monovision, and strabismus surgery. 展开更多
关键词 GLAUCOMA drainage Implant device DIPLOPIA MOTILITY BINOCULAR DISTURBANCE STRABISMUS
下载PDF
Electrocautery vs non-electrocautery dilation catheters in endoscopic ultrasonography-guided pancreatic fluid collection drainage 被引量:1
6
作者 Katsuya Kitamura Akira Yamamiya +3 位作者 Yu Ishii Tomohiro Nomoto Tadashi Honma Hitoshi Yoshida 《World Journal of Gastrointestinal Endoscopy》 CAS 2016年第13期458-465,共8页
AIM: To investigate the safety and utility of an electrocautery dilation catheter for endoscopic ultrasonography(EUS)-guided pancreatic fluid collection drainage.METHODS: A single-center, exploratory, retrospective st... AIM: To investigate the safety and utility of an electrocautery dilation catheter for endoscopic ultrasonography(EUS)-guided pancreatic fluid collection drainage.METHODS: A single-center, exploratory, retrospective study was conducted between August 2010 and August 2014. This study was approved by the Medical Ethics Committee of our institution. Informed, written consent was obtained from each patient prior to the procedure. The subjects included 28 consecutive patients who underwent EUS-guided transmural drainage(EUS-TD) for symptomatic pancreatic and peripancreatic fluid collections(PFCs) by fine needle aspiration using a 19-gauge needle. These patients were retrospectively divided into two groups based on the use of an electrocautery dilation catheter as a fistula dilation device; 15 patients were treated with an electrocautery dilation catheter(electrocautery group), and 13 patients were treated with a non-electrocautery dilation catheter(non-electrocautery group). We evaluated the technical and clinical successes and the adverse events associated with EUS-TD for the treatment of PFCs between the two groups.RESULTS: There were no significant differences in age, sex, type, location and diameter of PFCs between the groups. Thirteen patients(87%) in the electrocauterygroup and 10 patients(77%) in the non-electrocautery group presented with infected PFCs. The technical success rates of EUS-TD for the treatment of PFCs were 100%(15/15) and 100%(13/13) for the electrocautery and the non-electrocautery groups, respectively. The clinical success rates of EUS-TD for the treatment of PFCs were 67%(10/15) and 69%(9/13) for the electrocautery and the non-electrocautery groups, respectively(P = 0.794). The procedure time of EUS-TD for the treatment of PFCs in the electrocautery group was significantly shorter than that of the non-electrocautery group(mean ± SD: 30 ± 12 min vs 52 ± 20 min, P < 0.001). Adverse events associated with EUS-TD for the treatment of PFCs occurred in 0 patients and 1 patient for the electrocautery and the non-electrocautery groups, respectively(P = 0.942).CONCLUSION: EUS-TD using an electrocautery dilation catheter as a fistula dilation device for the treatment of symptomatic PFCs appears safe and contributes to a shorter procedure time. 展开更多
关键词 ELECTROCAUTERY DILATION catheter Endoscopic ultrasonography-guided transmural drainage Fistula DILATION device PANCREATIC and peripancreatic FLUID COLLECTION Procedure time
下载PDF
Glaucoma drainage implants 被引量:1
7
作者 Pavi Agrawal Palvi Bhardwaj 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2020年第8期1318-1328,共11页
Glaucoma drainage devices have traditionally been reserved for refractory glaucoma.However,there is an increasing body of evidence to suggest the use of these implants at an earlier stage in the surgical management of... Glaucoma drainage devices have traditionally been reserved for refractory glaucoma.However,there is an increasing body of evidence to suggest the use of these implants at an earlier stage in the surgical management of glaucoma.We describe the mechanics behind their function as well as the various implants available.The implants vary in size,surface area and composition and hence the surgical implantation of these devices are described in detail.The knowledge of such devices and their potential complications is fundamental for the successful management of patients who undergo aqueous-shunt surgery.Careful patient selection and optimal postoperative management is critical to the successful patient outcomes. 展开更多
关键词 GLAUCOMA glaucoma drainage devices aqueous shunts
下载PDF
Long-term Outcomes of Domestic Hunan Aqueous-Drainage Implantation in Refractory Glaucoma
8
作者 Yangfan Yang Xiahong Wang Minshi Pi 《Eye Science》 CAS 2011年第4期225-229,238,共6页
Purpose:To evaluate the long-term outcomes of a non-valved,.Chinese-made Hunan aqueous drainage device(HAD) in patients with refractory glaucoma,.compared to trabeculectomy.Methods:This was a retrospective observation... Purpose:To evaluate the long-term outcomes of a non-valved,.Chinese-made Hunan aqueous drainage device(HAD) in patients with refractory glaucoma,.compared to trabeculectomy.Methods:This was a retrospective observational case series,including 27 patients with refractory glaucoma who either underwent HAD implantation (n=11) or trabeculectomy (n=16).The mean follow-up was 27.9±13.5 (mean±SD) months.Intraocular pressure(IOP),visual acuity and postoperative complications were measured.Results:IOP was significantly lower at the last follow-up in both two groups compared with the baseline IOP (HAD:58.4 to 19.0 mmHg,P<0.001;trabeculectomy:58.4 to 23.7 mmHg,P<0.001).One week,1 month and 1 year after the operation,the average IOP of the HAD group was significantly lower than that of trabeculectomy group(P<0.05 at all time points).However,the IOP did not differ significantly between the two groups at the time of last follow-up.Conclusion:HAD implantation serves as a good option to control IOP in refractory glaucoma. 展开更多
关键词 引流装置 青光眼 植入 湖南 房水 国内 毫米汞柱 切除术
下载PDF
P50型与P200型Ex-PRESS引流器植入术对开角型青光眼疗效及安全性的随机对照研究 被引量:13
9
作者 韩光杰 周和政 +2 位作者 张文强 江文珊 刘川 《中华实验眼科杂志》 CAS CSCD 北大核心 2015年第3期246-249,共4页
背景 目前国外对Ex-PRESS引流器植入术治疗开角性青光眼的临床应用效果已有报道,在中国临床上使用的Ex-PRESS引流器有内径分别为50μm和200μm的P50型和P200型,但2种类型引流器的临床效果是否有所不同,目前国内外报道较少. 目的 对比观... 背景 目前国外对Ex-PRESS引流器植入术治疗开角性青光眼的临床应用效果已有报道,在中国临床上使用的Ex-PRESS引流器有内径分别为50μm和200μm的P50型和P200型,但2种类型引流器的临床效果是否有所不同,目前国内外报道较少. 目的 对比观察P50型与P200型Ex-PRESS引流器植入术治疗开角型青光眼的早期临床疗效和安全性. 方法 采用随机对照临床研究设计,纳入2012年3月至2013年4月在广州军区武汉总医院行Ex-PRESS引流器植入术的开角型青光眼患者69例80眼,采用随机数字表法将患者分为基线特征匹配的2个组,分别实施P50型Ex-PRESS引流器植入术(35例40眼)和Ex-PRESS引流器植入术(34例40眼),比较2个组患者的病种构成比、最佳矫正视力恢复时间、理论住院天数、手术前后的眼压变化及并发症的发生情况.结果 P50组和P200组术眼手术前后眼压平均下降幅度分别为(21.19±11.22)和(24.35±12.27)mmHg(1 mmHg=0.133 kPa),差异无统计学意义(t=-1.201,P>0.05).P50组患者的理论住院天数和最佳矫正视力恢复时间分别为(3.65±0.92)d和(2.85±0.95)d,明显少于P200组的(4.90±0.81)d和(3.40±0.96)d,差异均有统计学意义(t=-6.444,P<0.01;t=-2.584,P<0.05).P50组和P200组术眼术后并发症发生率分别为6.06%和25.00%,差异有统计学意义(x2=9.800,P<0.05),P50组术眼发生低眼压和浅前房的跟数少于P200组.结论 P50型和P200型Ex-PRESS引流器植入术对开角性青光眼的降眼压作用接近,与P200型Ex-PRESS引流器植入术比较,P50型Ex-PRESS引流器植入后早期患者的视力恢复快,并发症的发生率低. 展开更多
关键词 开角型青光眼/手术 青光眼引流植入物 微型化 眼压 治疗效果 术后并发症 ex-press引流器 随机对照研究
下载PDF
抗VEGF联合Ex-press青光眼引流器植入治疗新生血管性青光眼 被引量:7
10
作者 徐向忠 姚进 +2 位作者 宋雨晨 徐英男 曹国凡 《国际眼科杂志》 CAS 2016年第8期1564-1566,共3页
目的:观察玻璃体腔注射抗VEGF联合Ex-press青光眼引流器植入术对新生血管性青光眼的临床疗效。方法:回顾性分析我院收治的新生血管性青光眼患者20例20眼,15眼行玻璃体腔注射抗VEGF及Ex-press青光眼引流器植入联合PPV术,术中行全视网膜... 目的:观察玻璃体腔注射抗VEGF联合Ex-press青光眼引流器植入术对新生血管性青光眼的临床疗效。方法:回顾性分析我院收治的新生血管性青光眼患者20例20眼,15眼行玻璃体腔注射抗VEGF及Ex-press青光眼引流器植入联合PPV术,术中行全视网膜光凝术。另5眼行玻璃体腔注射抗VEGF及Ex-press青光眼引流器植入术,术后7d行全视网膜光凝。分别观察20例患者术中及术后并发症情况,以及术后1wk,1、3、6mo后的视力、眼压、虹膜新生血管消退情况。结果:治疗前平均眼压为47±5.6mmHg,治疗后1wk,1、3、6mo时平均眼压分别为13.4±3.6、15.3±4.2、16.9±5.3、18.7±6.9mmHg,治疗后各随访时间点眼压较治疗前差异具有统计学意义(P<0.05)。Ex-press青光眼引流器植入术术中及术后并发症主要有早期浅前房、引流管阻塞,经适当治疗后均恢复。滤过泡瘢痕化8眼,但眼压稳定在正常范围。结论:玻璃体腔注射抗VEGF联合Ex-press青光眼引流器植入术可以有效治疗新生血管性青光眼,降低新生血管性青光眼患者的眼压。 展开更多
关键词 新生血管性青光眼 ex-press青光眼引流器植入术 眼压
下载PDF
Ex-press青光眼引流器植入术治疗难治性青光眼的疗效及并发症 被引量:8
11
作者 骆晓琴 曹淑娟 马云成 《国际眼科杂志》 CAS 2016年第5期883-886,共4页
目的:探讨Ex-press青光眼引流器植入术治疗难治性青光眼的临床疗效及并发症。方法:随机选取本院2013-02/2014-08收治行Ex-press青光眼引流器植入术治疗的难治性青光眼53例56眼,男39例41眼,女14例15眼,平均年龄52.63±10.58岁;新... 目的:探讨Ex-press青光眼引流器植入术治疗难治性青光眼的临床疗效及并发症。方法:随机选取本院2013-02/2014-08收治行Ex-press青光眼引流器植入术治疗的难治性青光眼53例56眼,男39例41眼,女14例15眼,平均年龄52.63±10.58岁;新生血管性青光眼25例26眼,滤过手术失败后青光眼16例18眼,玻璃体切除术后继发青光眼6例6眼以及复杂眼外伤后青光眼6例6眼。观察术后1、12mo视力、眼压、前房深度、角膜内皮细胞密度及并发症等情况,并与术前进行分析比较。结果:术后12mo,完全成功率为62%(35眼),部分成功率为14%(8眼),总成功率为77%。其中新生血管性青光眼有效率为85%,滤过手术失败后青光眼有效率为56%,复杂眼外伤后青光眼100%,玻璃体切除术后青光眼83%。术后1mo视力较术前提高者28眼(50%),视力不变18眼(32%),视力降低10眼(18%)。术后12mo视力较术前提高者19眼(34%),视力不变18眼(32%),视力降低19眼(34%)。术前平均眼压29.58±8.66mm Hg,术后1mo平均眼压12.75±5.66mm Hg,与术前比较差异有统计学意义(P〈0.05),其中56例患眼眼压均表现为降低(100%)。术后12mo眼压为9.8~28.4(平均15.42±4.09)mm Hg,与术前比较差异有统计学意义(P〈0.05),其中眼压较术前增高者2眼,眼压不变0眼,眼压降低54眼(96%)。术后1、12mo内皮细胞计数分别为1958.22±168.30、1793.99±201.55个/mm2,与术前的2113.47±80.56个/mm2比较,差异有统计学意义(P〈0.01)。术后总并发症发生率为29%,其中术后早期发生浅前房低眼压4眼,暂时性高眼压3眼,引流管阻塞5眼,前房出血3眼。后期并发症有局部隆起的包裹的囊状泡1眼。结论:Ex-press青光眼引流器植入术治疗难治性青光眼,虽然存在一定的术后并发症,但仍可取得较好的临床疗效,是目前治疗难治性青光眼的有效方法。 展开更多
关键词 难治性青光眼 ex-press青光眼引流器 临床研究
下载PDF
Ex-press引流钉联合羊膜植入术中应用丝裂霉素C治疗外伤性青光眼(英文) 被引量:2
12
作者 童女侠 尹金福 +1 位作者 晋秀明 谢欣 《国际眼科杂志》 CAS 2017年第8期1399-1403,共5页
目的:观察外伤性开角型青光眼患者进行Ex-press引流钉联合羊膜植入术中应用丝裂霉素C后眼压及视力的变化。方法:前瞻性系列病例研究。连续收集行Ex-press引流钉联合羊膜植入术中应用丝裂霉素C治疗外伤性开角型青光眼患者18例18眼,分别... 目的:观察外伤性开角型青光眼患者进行Ex-press引流钉联合羊膜植入术中应用丝裂霉素C后眼压及视力的变化。方法:前瞻性系列病例研究。连续收集行Ex-press引流钉联合羊膜植入术中应用丝裂霉素C治疗外伤性开角型青光眼患者18例18眼,分别记录眼压(IOP)、最佳矫正视力(BCVA)、抗青光眼药物数量及并发症。所有患者随访24mo。结果:术后24mo,15眼取得了绝对成功(未使用抗青光眼药物时IOP<21 mmHg),成功率为88.2%(15/17)。术前IOP为36.9±4.8 mmHg,术后12mo为15.4±3.5 mmHg,术后24mo为15.5±3.5 mmHg。术后早期有2例患者(11.1%)由于滤过泡纤维化出现了高眼压。大多数患者最后一次复查时BCVA较术前有提高。2例患者(11.1%)术后出现一过性低眼压。术后无前房出血、脉络膜脱离、浅前房、引流器触碰虹膜或引流器脱位等并发症。结论:Ex-press引流钉联合羊膜植入术中应用丝裂霉素C治疗外伤性开角型青光眼是安全的、有效的,可以作为这类患者的选择。 展开更多
关键词 ex-press引流钉 青光眼引流器 外伤性青光眼
下载PDF
新型EX-PRESS青光眼引流器联合雷珠单抗治疗新生血管性青光眼 被引量:10
13
作者 刘志英 崔巍 《国际眼科杂志》 CAS 北大核心 2020年第5期847-851,共5页
目的:观察新型EX-PRESS青光眼引流器植入术联合雷珠单抗治疗新生血管性青光眼(NVG)的临床疗效及安全性。方法:选择2015-06/2018-06在我院确诊为NVG且行玻璃体腔注射雷珠单抗的患者78例78眼,将其中随访资料完整者60例60眼根据治疗方式不... 目的:观察新型EX-PRESS青光眼引流器植入术联合雷珠单抗治疗新生血管性青光眼(NVG)的临床疗效及安全性。方法:选择2015-06/2018-06在我院确诊为NVG且行玻璃体腔注射雷珠单抗的患者78例78眼,将其中随访资料完整者60例60眼根据治疗方式不同分为试验组30例30眼,行EX-PRESS青光眼引流器植入术。对照组30例30眼行常规小梁切除术。观察术后1wk,1、3、6mo及1a BCVA、眼压,术后早期并发症,于术后6mo,1a评估手术成功率。结果:术后1wk,1、3mo,试验组BCVA<0.1者25眼、25眼和23眼,平均眼压为16.76±3.21、15.63±2.70及16.69±3.29mmHg,对照组为26眼、26眼和25眼,平均眼压为17.31±2.96、14.44±2.53及16.56±4.14mmHg(均P>0.05);术后6mo,1a试验组BCVA<0.1者为16眼和16眼,平均眼压为15.49±3.19、18.52±4.03mmHg,对照组为25眼和25眼,平均眼压分别为21.96±2.90、28.90±4.33mmHg(均P<0.05);试验组术后低眼压、浅前房、前房出血、炎症反应、脉络膜脱离的发生例数分别为0眼、1眼、2眼、1眼、0眼,而对照组分别为6眼、6眼、5眼、4眼、2眼;试验组术后6mo,1a手术成功率为83%及80%,而对照组分别为60%及53%(P<0.05)。结论:EX-PRESS青光眼引流器植入术联合玻璃体腔注射雷珠单抗治疗NVG能够有效地降低患者的眼压,且具有手术切口小、操作简单、安全、术后并发症少、手术成功率高等优点。 展开更多
关键词 ex-press引流器植入术 新生血管性青光眼 雷珠单抗 小梁切除术
下载PDF
开角型青光眼患者行EX-PRESS青光眼引流钉植入围手术期护理 被引量:3
14
作者 林静仪 叶荣花 卢素芬 《现代临床护理》 2013年第8期49-51,共3页
目的探讨开角型青光眼患者行EX-PRESS青光眼引流钉植入围手术期护理要点。方法给予18例患者行EX-PRESS青光眼引流钉植入术,并做好围手术期护理工作。结果18例患者均成功植入引流钉,手术时间25~45 min,平均(30.0±5.0)min,术... 目的探讨开角型青光眼患者行EX-PRESS青光眼引流钉植入围手术期护理要点。方法给予18例患者行EX-PRESS青光眼引流钉植入术,并做好围手术期护理工作。结果18例患者均成功植入引流钉,手术时间25~45 min,平均(30.0±5.0)min,术后眼内压稳定。结论 EX-PRESS青光眼引流钉植入术是治疗开角型青光眼疾病的一种有效方法,做好围手术期护理工作是确保治疗效果的重要措施。 展开更多
关键词 EX—PRESS青光眼引流钉植入术 开角型青光眼 围手术期护理
下载PDF
EX-PRESS青光眼引流器植入术联合超声乳化术治疗原发性急性闭角型青光眼合并白内障的临床疗效 被引量:17
15
作者 黄宝辉 《广西医学》 CAS 2020年第16期2112-2115,共4页
目的探讨EX-PRESS青光眼引流器植入术联合超声乳化术在治疗原发性急性闭角型青光眼合并白内障中的临床疗效。方法将80例(82眼)原发性急性闭角型青光眼合并白内障患者根据手术方式分为对照组(40例40眼)和观察组(40例42眼)。观察组患者采... 目的探讨EX-PRESS青光眼引流器植入术联合超声乳化术在治疗原发性急性闭角型青光眼合并白内障中的临床疗效。方法将80例(82眼)原发性急性闭角型青光眼合并白内障患者根据手术方式分为对照组(40例40眼)和观察组(40例42眼)。观察组患者采用EX-PRESS青光眼引流器植入术联合白内障超声乳化术治疗,对照组患者采用房角分离术联合白内障超声乳化术治疗。比较术前、术后7 d、1个月、3个月及6个月两组患者的最佳矫正视力(logMAR视力)、眼压、中央前房深度,评估术后两组患者的临床疗效,记录两组患者并发症发生情况。结果术后7 d、1个月、3个月及6个月,两组患者logMAR视力、眼压均较术前降低,中央前房深度较术前增加;观察组的logMAR视力低于对照组(P<0.05),而除术后1个月时观察组的中央前房深度大于对照组外,其余各时点两组间眼压及中央前房深度差异无统计学意义(P>0.05)。术后6个月观察组手术治疗成功率高于对照组(P<0.05),而两组术后并发症发生率差异无统计学意义(P>0.05)。结论EX-PRESS青光眼引流器植入术联合超声乳化术治疗原发性急性闭角型青光眼合并白内障的临床疗效确切,有利于快速降低患者眼压,提高视力,且不增加术后并发症的发生,值得临床推广应用。 展开更多
关键词 ex-press青光眼引流器植入术 超声乳化术 原发性急性闭角型青光眼 白内障
下载PDF
雷珠单抗联合EX-PRESS青光眼引流器植入与雷珠单抗联合Ahmed阀植入治疗新生血管性青光眼的效果研究 被引量:3
16
作者 倪宝玲 赵平 《中国实用医药》 2021年第23期89-92,共4页
目的对比雷珠单抗联合EX-PRESS青光眼引流器植入与雷珠单抗联合Ahmed阀植入治疗新生血管性青光眼(NVG)的临床疗效。方法42例(42眼)新生血管性青光眼患者,根据手术方式不同分为A组(16例,16眼)和B组(26例,26眼)。A组采用雷珠单抗联合EX-PR... 目的对比雷珠单抗联合EX-PRESS青光眼引流器植入与雷珠单抗联合Ahmed阀植入治疗新生血管性青光眼(NVG)的临床疗效。方法42例(42眼)新生血管性青光眼患者,根据手术方式不同分为A组(16例,16眼)和B组(26例,26眼)。A组采用雷珠单抗联合EX-PRESS青光眼引流器植入治疗,B组采用雷珠单抗联合Ahmed阀植入治疗。对比两组患者手术成功率及术后并发症发生情况,组内眼压情况。结果A组术后1 d、1周、1个月、3个月、6个月、12个月眼压均低于术前,差异有统计学意义(t=16.005、13.188、13.554、13.359、12.887、12.820,P<0.05)。B组术后1 d、1周、1个月、3个月、6个月、12个月眼压均低于术前,差异有统计学意义(t=10.212、10.898、10.004、9.644、9.025、8.839,P<0.05)。A组手术成功率为62.5%(10/16)低于B组的88.5%(23/26),差异有统计学意义(χ^(2)=3.965,P<0.05)。A组术后并发症发生率31.3%低于B组的65.4%,差异有统计学意义(χ^(2)=4.627,P<0.05)。结论雷珠单抗联合EX-PRESS青光眼引流器植入与雷珠单抗联合Ahmed阀植入治疗新生血管性青光眼均可降低眼压,雷珠单抗联合EX-PRESS青光眼引流器植入安全性优于雷珠单抗联合Ahmed阀植入,但手术成功率低于雷珠单抗联合Ahmed阀植入。 展开更多
关键词 雷珠单抗 ex-press青光眼引流器 Ahmed阀 新生血管性青光眼
下载PDF
Ex-PRESS青光眼引流器植入术与复合式小梁切除术术后黄斑中心凹厚度变化的研究 被引量:2
17
作者 倪宝玲 赵平 《中国实用医药》 2020年第14期25-28,共4页
目的比较Ex-PRESS青光眼引流器植入术与复合式小梁切除术对原发性开角型青光眼患者术眼术后黄斑中心凹厚度的影响。方法27例(48眼)原发性开角型青光眼患者,根据手术方式不同分为A组(14例,24眼)和B组(13例,24眼)。A组患者行Ex-PRESS青光... 目的比较Ex-PRESS青光眼引流器植入术与复合式小梁切除术对原发性开角型青光眼患者术眼术后黄斑中心凹厚度的影响。方法27例(48眼)原发性开角型青光眼患者,根据手术方式不同分为A组(14例,24眼)和B组(13例,24眼)。A组患者行Ex-PRESS青光眼引流器植入术进行治疗,B组患者行复合式小梁切除术进行治疗。测量记录两组患者术前及术后3 d、1个月、3个月、6个月的术眼眼压、最佳矫正视力、黄斑中心凹厚度,并比较本组内治疗前后变化情况。结果A组患者术前及术后3 d、1个月、3个月、6个月的眼压分别为(20.19±1.99)、(14.05±1.65)、(13.67±1.38)、(13.36±1.00)、(13.61±1.11)mm Hg(1 mm Hg=0.133 kPa),术后3 d、1个月、3个月、6个月的眼压均低于术前,差异均具有统计学意义(P<0.05)。B组患者术前及术后3 d、1个月、3个月、6个月的眼压分别为(19.89±2.83)、(14.55±1.86)、(14.64±1.82)、(14.05±1.44)、(14.27±1.73)mm Hg,术后3 d、1个月、3个月、6个月的眼压均低于术前,差异均具有统计学意义(P<0.05)。A组患者术前及术后3 d、1个月、3个月、6个月最佳矫正视力为(0.75±0.17)、(0.74±0.18)、(0.76±0.18)、(0.74±0.20)、(0.77±0.19);A组患者术后3 d、1个月、3个月、6个月最佳矫正视力与术前比较,差异均无统计学意义(P>0.05)。B组患者术前及术后3 d、1个月、3个月、6个月最佳矫正视力为(0.47±0.23)、(0.46±0.21)、(0.45±0.20)、(0.44±0.20)、(0.47±0.22);B组患者术后3 d、1个月、3个月、6个月最佳矫正视力与术前比较,差异均无统计学意义(P>0.05)。A组患者术前及术后3 d、1个月、3个月、6个月的黄斑中心凹厚度分别为(232.25±16.90)、(236.21±16.16)、(235.17±6.68)、(232.58±16.55)、(232.17±16.58)μm;术后3 d、1个月黄斑中心凹厚度较术前增加,差异均具有统计学意义(P<0.05);术后3个月、6个月黄斑中心凹厚度恢复与术前比较,差异均无统计学意义(P>0.05)。B组患者术前及术后3 d、1个月、3个月、6个月的黄斑中心凹厚度分别为(225.50±3.46)、(228.38±3.56)、(231.17±3.37)、(227.04±3.44)、(225.58±3.30)μm;术后3 d、1个月、3个月黄斑中心凹厚度较术前增加,差异均具有统计学意义(P<0.05);术后6个月黄斑中心凹厚度恢复与术前比较,差异无统计学意义(P>0.05)。结论Ex-PRESS青光眼引流器植入术与复合式小梁切除术均可以安全有效的降低原发性开角型青光眼患者的眼压,均未造成黄斑中心凹厚度的不可逆改变,Ex-PRESS青光眼引流器植入术影响较小,恢复较快,安全性较高。 展开更多
关键词 ex-press青光眼引流器植入术 小梁切除术 原发性开角型青光眼 黄斑中心凹厚度
下载PDF
Ex-Press引流器在眼科应用新进展 被引量:2
18
作者 钟敏 《现代诊断与治疗》 CAS 2016年第15期2796-2798,共3页
Ex-press青光眼引流器是一种由不锈钢材料制造的房水引流装置,Ex-Press青光眼引流器植入术(以下简称Ex-Press手术)的开展,是一类新型的青光眼治疗方案。临床中形成共识的手术适应证为前房较深的眼压控制不良的青光眼患者,尤其成为解决... Ex-press青光眼引流器是一种由不锈钢材料制造的房水引流装置,Ex-Press青光眼引流器植入术(以下简称Ex-Press手术)的开展,是一类新型的青光眼治疗方案。临床中形成共识的手术适应证为前房较深的眼压控制不良的青光眼患者,尤其成为解决难治性青光眼患者的更佳选择。经研究发现,巩膜瓣下Ex-Press手术联合抗代谢药物应用降眼压效果更为确切。与传统青光眼滤过手术相比,Ex-Press手术操作简单,并发症少,术后降眼压效果确切,并且可重复操作,临床应用前景广阔。 展开更多
关键词 ex-press青光眼引流器 难治性青光眼 新生血管性青光眼 手术治疗
下载PDF
Ex-PRESS引流器治疗开角型青光眼的临床应用 被引量:1
19
作者 刘永坚 陈真 +2 位作者 李勇 陈瑞中 毛华敏 《黑龙江医学》 2016年第7期606-608,共3页
目的探究Ex-PRESS引流器治疗开角型青光眼的临床效果。方法选取40例开角型青光眼患者作为本次实验研究对象。结果两组患者均成功完成手术,治疗组患者手术时间及住院时间明显短于对照组,差异有统计学意义(P<0.05);治疗组并发症率较对... 目的探究Ex-PRESS引流器治疗开角型青光眼的临床效果。方法选取40例开角型青光眼患者作为本次实验研究对象。结果两组患者均成功完成手术,治疗组患者手术时间及住院时间明显短于对照组,差异有统计学意义(P<0.05);治疗组并发症率较对照组低,差异有统计学意义(P<0.05);治疗组术后3个月眼压控制及视力情况明显优于对照组,治疗组使用药物率明显低于对照组,差异有统计学意义(P<0.05)。结论 Ex-PRESS引流器植入术治疗开角型青光眼成功率高,手术时间短,术后并发症少,使用抗青光眼药物少,安全性高,患者眼压控制好,具有较高临床应用与推广价值。 展开更多
关键词 开角型青光眼 ex-press引流器 小梁切除术 眼压 视力
下载PDF
Ex-press青光眼引流器与小梁切除术治疗开角型青光眼的比较 被引量:5
20
作者 朱玄生 陶黎明 +2 位作者 蒋正轩 刘贺婷 张青 《国际眼科杂志》 CAS 2017年第5期917-920,共4页
目的:观察Ex-press青光眼引流器植入术治疗开角型青光眼的疗效。方法:回顾性分析。收集2014-01/2016-05于安徽医科大学第二附属医院确诊为开角型青光眼并行两种手术治疗的患者临床资料,统计患者的性别、年龄、手术前后视力、眼压、角膜... 目的:观察Ex-press青光眼引流器植入术治疗开角型青光眼的疗效。方法:回顾性分析。收集2014-01/2016-05于安徽医科大学第二附属医院确诊为开角型青光眼并行两种手术治疗的患者临床资料,统计患者的性别、年龄、手术前后视力、眼压、角膜内皮细胞计数及术后并发症的数据,并进行比较分析。结果:Ex-press青光眼引流器与小梁切除术术后6mo视力比较无统计学差异(P>0.05)。两组患者术后眼压与术前相比均下降,差异有统计学意义(P<0.01),但术后两组间各个时间点比较均无统计学差异。术后6mo,Ex-press青光眼引流器组角膜内皮细胞计数与术前比较无统计学差异(P>0.05),而小梁切除术组存在统计学差异(P<0.05)。Ex-press青光眼引流器组术后并发症的发生率为15%,小梁切除术为43%,两组间并发症比较有统计学差异(P<0.05)。结论:Ex-press青光眼引流器植入术与小梁切除术治疗开角型青光眼疗效相似,但前者对于角膜内皮的影响较小,且并发症发生率更低。 展开更多
关键词 ex-press青光眼引流器 小梁切除术 开角型青光眼 眼压
下载PDF
上一页 1 2 26 下一页 到第
使用帮助 返回顶部